IIM
AQST icon

INTECH Investment Management’s Aquestive Therapeutics AQST Stock Holding History

INTECH Investment Management’s Portfolio AQST Stock Details AQST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$107K Sell
25,718
-8,195
-24% -$33.3K ﹤0.01% 1882
2025
Q4 		$219K Buy
33,913
+12,566
+59% +$78.3K ﹤0.01% 1934
2025
Q3 		$119K Sell
21,347
-33,046
-61% -$143K ﹤0.01% 2216
2025
Q2 		$180K Buy
54,393
+12,600
+30% +$36.1K ﹤0.01% 2127
2025
Q1 		$121K Buy
41,793
+2,116
+5% +$6.41K ﹤0.01% 2262
2024
Q4 		$141K Buy
39,677
+21,645
+120% +$99.8K ﹤0.01% 2134
2024
Q3 		$89.8K Buy
+18,032
New +$70.2K ﹤0.01% 1902

Other funds holding AQST

BCM
Bratton Capital Management Fort Worth, Texas $40.7M AUM 43.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

INTECH Investment Management's AQST Position: Q1 2026 in Review

INTECH Investment Management reduced its Aquestive Therapeutics (AQST) stake by 24% in Q1 2026, selling an estimated $33.3K and leaving 25,718 shares worth $107K. The position accounts for ﹤0.01% of the portfolio, ranked #1882.

INTECH Investment Management first reported a position in AQST in Q3 2024 and has held it in 7 quarters since. The position peaked at $219K in Q4 2025. 179 funds tracked by Wall St. Rank hold AQST as of Q1 2026.

  • INTECH Investment Management held 25,718 shares of Aquestive Therapeutics worth $107K as of Q1 2026.
  • INTECH Investment Management sold 8,195 Aquestive Therapeutics shares in Q1 2026, an estimated $33.3K.
  • Aquestive Therapeutics made up ﹤0.01% of INTECH Investment Management's portfolio in Q1 2026, its #1882 holding.
  • INTECH Investment Management first reported a position in Aquestive Therapeutics in Q3 2024 and has held it in 7 quarters since.
  • INTECH Investment Management's Aquestive Therapeutics position peaked at $219K in Q4 2025.
  • 179 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q1 2026.

Based on INTECH Investment Management's 13F filing for Q1 2026, filed 8 May 2026.